The transcription factor Orthodenticle homeobox 2 (OTX2) has been implicated in the pathogenesis of medulloblastoma, as it is often highly expressed and sometimes amplified in these tumors. Little is known of the downstream pathways regulated by OTX2. We therefore generated MED8A and DAOY medulloblastoma cell lines with doxycycline-inducible OTX2 expression. In both cell lines, OTX2 inhibited proliferation and induced a senescence-like phenotype with senescence-associated β-galactosidase activity. Expression profiles of time series after OTX2 induction in MED8A showed early upregulation of cell cycle genes related to the G2-M phase, such as AURKA, CDC25C, and CCNG2. Paradoxically, G1-S phase genes such as MYC, CDK4, CDK6, CCND1, and CCND2 were strongly downregulated, in line with the observed G1 arrest. ChIP-on-chip analyses of OTX2 binding to promoter regions in MED8A and DAOY showed a strong enrichment for binding to the G2-M genes, suggesting a direct activation. Their mRNA expression correlated with OTX2 expression in primary tumors, underscoring the in vivo relevance of this regulation. OTX2 induction activated the P53 pathway in MED8A, but not in DAOY, which carries a mutated P53 gene. In DAOY cells, senescence-associated secretory factors, such as IL-6 and IGFBP7, were strongly upregulated after OTX2 induction. We hypothesize that the imbalance in cell cycle stimulation by OTX2 leads to cellular senescence either by activating the P53 pathway or through the induction of secretory factors. Our data indicate that OTX2 directly induces a series of cell cycle genes but requires cooperating genes for an oncogenic acceleration of the cell cycle.
Introduction
Medulloblastoma is the most common malignant brain tumor in children and accounts for ∼10% of all childhood cancer deaths. Although overall survival rates are improving in recent years, current therapies are still associated with serious long-term side effects, including many cognitive defects. A better understanding of the molecular biology of medulloblastomas is needed to find novel treatment modalities and improve overall survival and quality of life.
One of the genes implicated in medulloblastoma tumorigenesis is orthodenticle homeobox 2 (OTX2). SAGE analyses initially identified OTX2 as highly expressed in medulloblastoma [1] .
Subsequently, OTX2 was also found to be strongly amplified in a set of primary tumors and cell lines, suggesting that this gene acts as an oncogene in medulloblastoma [2] [3] [4] . The OTX2 gene encodes a member of the bicoid subfamily of homeodomain-containing transcription factors that is essential in brain and sensory organ development [5] [6] [7] (5-7). Mouse models have shown that deletion of both Otx2 alleles is lethal, whereas decreased levels of Otx2 result in serious malformations of the brain, including cerebellum [7, 8] . During cerebellum development, OTX2 is expressed in proliferating progenitor cells in the external granular cell layer, but expression disappears when these cells migrate to the internal granular cell layer and become fully differentiated [2] . No OTX2 was detected in postnatal cerebellum.
However, immunohistochemical staining of 152 primary tumors showed OTX2 protein expression in 114 (75%) of all medulloblastomas [2] . The OTX2 expression strongly correlated with a classic histology, whereas desmoplastic histology mainly occurred in tumors without OTX2 expression. We recently generated mRNA profiles of 62 medulloblastomas [9] . Five molecular subtypes in medulloblastoma were identified with distinct genetic profiles, pathway signatures, and clinicopathologic features. OTX2 was highly expressed in four subtypes (A, C, D, and E), but is not or only weakly expressed in subtype B. These type B tumors frequently showed desmoplastic histology.
The biological role of OTX2 in these different molecular subtypes of medulloblastoma is still unknown. Silencing OTX2 expression in medulloblastoma cell lines reduced cell proliferation and tumor formation [4, 10] . These data suggest a crucial role for OTX2 in medulloblastoma, but the transcriptional targets and pathways controlled by OTX2 remain unknown. To investigate OTX2 and downstream pathways, we made use of the MED8A and DAOY medulloblastoma cell lines, which lack endogenous OTX2 expression.
Clones with doxycycline-inducible ectopic OTX2 expression were generated. OTX2 overexpression resulted in a reduced cell proliferation and a senescent phenotype. To 36 identify the transcriptional network of OTX2 that may explain the phenotype of OTX2-induced senescence, we performed mRNA profiling of a time series after OTX2 induction in MED8A cells as well as OTX2 chromatin immunoprecipitation followed by promoter array analysis (ChIP-on-chip). Data were validated in DAOY cells with OTX2 induction. Finally, we combined all data with the tumor mRNA profiles to validate the functional OTX2 targets in medulloblastoma tumors.
Material en Methods

Cell lines, constructs, and transfection procedures
Medulloblastoma cell lines were cultured in DMEM (Richter's modification) (MED8A, UW228-2, D458, D556, and D283) or MEM (DAOY, D425, and D341; Invitrogen), supplemented with 10% fetal bovine serum, 0.1 mmol/L MEM nonessential amino acids, 200 mmol/L glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin (Invitrogen) at 37°C in a humified atmosphere containing 5% CO 2 Transfected cells were cultured in selective medium with 100 μg/mL zeocin (Invitrogen) to generate stable clones. To induce OTX2 expression, doxycycline (MP Biochemicals) was added to the cells 24 hours after plating in a final concentration of 100 ng/mL.
Western blotting and antibodies
For preparation of protein extracts, ice-cold buffer containing 10 mmol/L Tris (pH 7.5), 150 mmol/L NaCl, 1% NP40, 1% sodium deoxycholate, 0.1% SDS, complete proteinase inhibitor (Roche Applied Sciences), 0.5 μmol/L NaF, and 0.5 μmol/L Na 3 VO 4 was added to the cells.
Plates were incubated for 10 minutes on ice. DNA was sheared and lysates were cleared by centrifugation. For cytoplasmic and nuclear fractions, the ProteoExtract Subcellular Proteome Extraction Kit (EMD Chemicals Inc.) was used.
Protein was quantified using the detergent-compatible protein assay (Bio-Rad). SDS-PAGE gels were run with 5 to 30 μg of protein and electroblotted onto an Immobilon-P membrane (Millipore, Billerica). Blocking and incubation were done in 1X TBS with 0.05% Tween 20 and 5% dry milk using standard procedures. OTX2 mouse monoclonal antibody was a gift from Dr. G. Corte (Department of Translational Oncology, National Institute for Cancer Research, Genova, Italy). Other antibodies were commercially obtained: GAPDH, p-P53, p-ERK1/2 (Cell Signaling Technology), histone H3 (Upstate Cell Signaling Solutions), MYC (Roche Applied Sciences), TUBA (Sigma), RB (BD Biosciences), CCND2, CDK4, CDK6, p-RB (Santa Cruz Biotechnology), CCND1, P16, P21, P27, and P53 (Neomarkers), IL-6, IGFBP7
(Abcam) and SPRY2 (Abnova). After incubation with a secondary sheep anti-mouse or antirabbit horseradish peroxidase-linked antibody (GE Healthcare), proteins were visualized by enhanced chemiluminescence (GE Healthcare).
Growth assay
Uninduced cells and 72-hour induced cells were plated in 96-well microplates. After 4 days, cell viability was measured by adding 25 μL of 3 mg/mL MTT (Sigma) and incubating for 2 to 4 hours at 37°C. Medium was discarded and the remaining precipitate was solubilized by the addition of 50 μL of DMSO. Subsequently, absorbance was measured at 570 and 650 nm (reference) on a Bio-Rad 3550 microplate reader equipped with a spectrophotometer (BioRad). Cell viability was expressed as relative signal compared with uninduced cells, after correction for background absorbance.
Fluorescence-activated cell sorting (FACS) analysis
For quantification of cell cycle distribution, 100 ng/mL doxycycline was added to cells 24 hours after plating. After 72 hours of induction, cells were trypsinized and washed. Pellet was resuspended in 0.1X PBS containing 7.5 μmol/L propidium iodide and 50 μg/mL RNase A. After a minimal incubation time of 1 hour, cells were analyzed on a BD FACSCanto flow cytometer (BD Bioscience). Obtained data were analyzed using FlowJo 7.2 software (Tree Star, Inc.).
Senescence-associated β-galactosidase staining
To assess senescence-associated β-galactosidase activity, cells were washed with 1X PBS and fixed by incubation in 3% paraformaldehyde. After subsequent washing with 1X PBS, cells were incubated overnight in a 37°C incubator with X-gal staining solution [1 mg/mL X-gal (Invitrogen), 150 mmol/L NaCl, 2 mmol/L MgCl2, 5 mmol/L K 3 Fe(CN) 6 , 5 mmol/L K 4 Fe(CN) 6 in phosphate buffer (pH 6)]. Pictures were taken using a DMIL microscope with a DC300 camera and IM 500 software (Leica). 38 
RNA extraction and expression profiling
For expression profiling, total RNA was extracted with Trizol reagent (Invitrogen) according to the manufacturer's instructions. RNA was purified using the RNeasy Mini Kit (Qiagen). RNA quantity and quality were determined by spectrophotometry (Nanodrop) and microfluidics- 
Data analyses
All expression data were normalized with the MAS5.0 algorithm of GCOS program (Affymetrix).
Target intensity was set to 100 (α1 = 0.04 and α2 = 0.06). Detection P values were assigned to each probe set using the MAS5.0 algorithm (trimmed mean 96 = 100). In case of multiple probe sets for one gene, the probe set with the highest expression and correct mapping was used. Publicly available HG U133 Plus 2.0 microarray expression data were obtained from the National Cancer Institute Gene Expression Omnibus database. GSE3526 contains 353 normal tissue samples from the whole body (central nervous system (CNS) and non-CNS) [11] . GSE4290 [12] contains 180 samples derived from normal brain and brain tumor samples (glioblastoma, astrocytoma, and oligodendroglioma). We used only the data for the 153 tumor samples in this series, which were clearly annotated. GSM97826, GSM97836, GSM97858, and GSM97879 were therefore left out. GSE7307 contains expression data for other tumors and normal tissues from different sites. All these data were processed as described above. All analyses were done using the in-house developed software, called R2.
For the MED8A-OTX2 time course, the following criteria applied for genes to be considered significantly regulated. First, the probe set should have minimally 1 present call within the experiment. Second, at least one expression value should exceed an expression value of 50.
Finally, compared with T = 0, a minimum fold change of 0.5 2 log with P < 0.00005 is required. K-means clustering was done using the TMEV program [13] . Genes were annotated using the Functional Annotation Tool of DAVID [14] . For Gene Ontology enrichment analyses, we used all expressed genes within the experiment as background in these analyses. Enrichment was considered when the enrichment score for levels 4 and 5 in biological processes was higher than 2.5. To identify genes that correlate with OTX2 expression in vivo, we used the mRNA profiling data of primary tumors [9] . Only genes with a minimum of 1 present call were included. Data were extracted using R2 software. 39 
Luciferase assay
To monitor P53 transcriptional activity after OTX2 induction, MED8A-OTX2 and MED8A-control cells were transfected in a 24-well plate with 125 ng of pG13-luc or pM15-luc (kindly provided by Bert Vogelstein, Ludwig Center for Cancer Genetics and Therapeutics, Johns
Hopkins Kimmel Cancer Center, Baltimore, MD) using Fugene HD (Roche Applied Sciences) [15] . As a normalization control, 20 ng of pGL4.74 (Promega) were included. Luciferase activity was monitored using the dual-luciferase reporter assay kit (Promega) according to the manufacturer's protocol using the Synergy HT Multi-Mode Microplate Reader (BioTek).
P53 mutational analysis
Exons 5 to 8 of P53 were sequenced using BigDye Terminator v1.1 chemistry (Applied Biosystems; Supplementary Table S7 ). Sequencing was done on an ABI 3730 capillary sequencer (Applied Biosystems). Electropherograms were analyzed using Codon Code aligner. were added and incubated at 45°C for 1 hour to degrade protein. RNA was degraded by adding 5 μL of 10 mg/mL RNase A (Roche) and incubating for 30 minutes at 37°C. DNA was purified using Qiagen PCR purification kit (Qiagen) and quantified with Quant-IT Picogreen (Invitrogen). 40 The recovered DNA was amplified for labeling as described previously [16] . Labeling of the material, hybridization to the 2.1M Deluxe Promoter Array, scanning of the arrays, and peak calling were performed by Nimblegen, Inc. All peaks as called by the Nimblegen algorithm were assigned to transcriptional start sites (TSS). Peaks were regarded as unique when no peak was detected within a region surrounding a TSS in the control experiment. Raw data were visualized using the R2 program.
ChIP-on-chip analysis
Results
OTX2 expression is specific for medulloblastoma
Analysis of mRNA expression data showed that OTX2 is highly expressed in medulloblastoma, but not in other brain or non-brain tumors or normal tissues ( Figure 1A ). Expression profiling of medulloblastoma cell lines showed that five cell lines (D283, D341, D425, D458, and D556) also highly expressed OTX2, comparable to the levels observed in tumors ( Figure 1A ). Most likely, these cell lines were derived from type E tumors, as they have gain of 17q, expression of MYC and retinal genes, and no CTNNB1 mutations (9, 17) . Three cell lines (UW228-2, MED8A, and DAOY) without OTX2 expression were most likely derived from type B tumors.
For instance, they all lack 17q gain, lost 9q (MED8A) [17] , were derived from a desmoplastic tumor (DAOY) [18] , and all have low NEUROG1 expression.
Overexpression of OTX2 in MED8A and DAOY medulloblastoma cell lines
We selected the MED8A and DAOY cell lines [18, 19] , which have no endogenous OTX2 expression, to investigate the effect of OTX2. We generated two clones, MED8A-OTX2 and DAOY-OTX2, which have doxycycline-inducible OTX2 expression ( Figure 1B ). No OTX2 protein expression can be detected in uninduced cells ( Figure 1B ) or MED8A and DAOY parental cells (data not shown). OTX2 protein was expressed within 4 hours after addition of doxycycline and reached maximum levels within 24 hours. The induced levels of OTX2 were comparable to the endogenous OTX2 levels in the medulloblastoma cell line D425, which has a strong amplification of the OTX2 gene ( Figure 1C ) [2] [3] [4] . Moreover, in all three cell lines, OTX2 was detected only in the nuclear fraction ( Figure 1C ). The two cell lines with inducible OTX2 therefore represent a good model for the analysis of OTX2 at physiologically relevant levels in medulloblastoma.
OTX2 induces a senescence-like phenotype
OTX2 overexpression reduced the proliferation of MED8A and DAOY cells. After 1 week of OTX2 induction, the number of viable cells was reduced by half in both cell lines compared 41 with uninduced cells (Figure 2A ). However, time course analyses of cell proliferation performed early after OTX2 induction showed that up to 24 hours, cell numbers first slightly increased and, after 48 hours, started to decrease (Supplementary Figure S1) . For MED8A, Histone H3 and TUBA were used as loading controls.
42
FACS analyses revealed that the reduced proliferation was accompanied by a significant increase of cells in G1-phase, whereas the S and G2-M fractions decreased ( Figure 2B and Supplementary Figure S2) . In DAOY cells, however, OTX2 induction resulted in a significant increase of cells in G2-M-phase ( Figure 2B ). This difference in cell cycle distribution after OTX2 induction may be related to the difference in P53 status. Sequence analysis showed that MED8A cells are wild-type for P53, but DAOY cells harbor a homozygous P53 mutation [20] . We found no indications for increased apoptosis induced by OTX2 because in both cell lines the sub-G1 fractions did not increase with time, nor did PARP or CASP3 cleavage (Supplementary Figure S3) . Furthermore, sustained induction of OTX2 in MED8A or DAOY cells resulted in clear morphologic changes. Cells became flattened and showed an increase in the amount of cytoplasm ( Figure 2C ). Also, some multinucleated cells were observed.
As these features are characteristic of senescent cells, we stained both cell lines for senescence-associated β-galactosidase. β-Galactosidase activity was detected in cells with OTX2 expression, but not in control cells ( Figure 2D ). The presence of this β-galactosidase staining together with the decreased proliferation and change in morphology strongly suggests that OTX2 induces senescence in both medulloblastoma cell lines.
OTX2 induces strong changes in gene expression profile
Because OTX2 is a transcription factor, we were interested in the changes in gene expression after OTX2 induction. A time series analysis of MED8A-OTX2 cells was done using Affymetrix HG U133 Plus 2.0 Arrays. RNA was isolated at 0, 8, 24, and 48 hours after induction of OTX2.
Expression of 12,781 genes could be detected in MED8A-OTX2 cells, of which 2,009 were regulated after OTX2 expression ( 2 log-fold regulation ≥0.5 with P < 0.00005; Supplementary Table S1 ).
OTX2 first stimulates mitotic genes before cells go into senescence
To identify patterns in gene regulation after OTX2 induction, we performed K-means clustering on all genes regulated over time. Nine clusters with distinct regulation patterns were identified (Figure 3 Table S2 ) [14] . Early induction of specific functional groups was detected in clusters I, IV, and IX. Cluster IX was significantly enriched in genes functioning in mitosis and sister chromosome segregation, such as AURKA, CDC25C, CCNG2, CENPA, and CENPE. They were rapidly upregulated after OTX2 induction, but their expression decreased again after 24 hours ( Figure 4A ). Clusters I and IV, consisting of early regulated 43 genes, were enriched for genes involved in transcription. The late regulated cluster II was significantly enriched for genes involved in ribosome biogenesis and protein translation.
Their downregulation may reflect the observed phenotype of reduced proliferation after Figure S1) .
OTX2 expression inhibits G1-S cell cycle progression
Most G2-M genes that were induced by OTX2 overexpression in MED8A were highly expressed in all medulloblastomas ( Figure 4A and Supplementary Table S1), suggesting that OTX2 might be responsible for their high expression in tumors. Surprisingly, a group of G1-S-phase-specific genes, such as CCND1, CCND2, CDK4, CDK6, and MYC, were all strongly downregulated by OTX2 ( Figure 4B) . Nevertheless, these genes are generally highly expressed in medulloblastoma ( Figure 4B and Supplementary Table S1 ). Strikingly, P27, as well as CCND1, CCND2, MYC, CDK4, and CDK6 were determined for MED8A-OTX2 at different time points after induction of OTX2. As expected, by expression profiling, CCND1, CCND2, MYC, CDK4, and CDK6 were found to be downregulated, whereas P21 and P27 levels increased with time. P16 levels did not change. TUBA was used as a loading control.
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G1-S transition inhibitors such as P15 (CDKN2B), P21 (CDKN1A), P27 (CDKN1B), and P57
(CDKN1C) were all upregulated by OTX2 in MED8A (Supplementary Table S1 ). To validate the paradoxical regulation of G1-S and G2-M genes, we analyzed protein lysates from time-series experiments of MED8A-OTX2. The levels of CCND1, CCND2, CDK4, CDK6, and MYC proteins were quickly downregulated after OTX2 induction ( Figure 4C ). Despite the differences in cell cycle distribution between MED8A and DAOY cells after OTX2 induction, most of these proteins were also downregulated in DAOY cells (Supplementary Figure S4) . Moreover, protein levels of P21 and P27 were increased in MED8A cells. In DAOY cells, however, which are inhibited in G2-M, these proteins were not upregulated. Our results show that induction of OTX2 in MED8A cells inhibits the expression of G1-S-phase genes and, at the same time, stimulates expression of G2-M genes, suggesting that unbalanced regulation of cell cycle progression might cause oncogenic stress in the cells.
OTX2 expression results in P53 pathway activation in MED8A cells
The P53 pathway is responsive to cell cycle stress and is involved in senescence [21, 22] .
We therefore asked whether this pathway was activated after OTX2 induction in MED8A cells. Gene Ontology analyses [14] performed for the complete set of regulated genes in the time series identified the P53 pathway as most affected by OTX2, with 23 of its genes being regulated (Supplementary Table S2 Table S1 ) [23] .
Examples include P21, GADD45A, and BAX. Western blot analysis confirmed the increased expression of P21 after OTX2 induction ( Figure 4C ). P53 mRNA levels did not change, but OTX2 induction resulted in increased nuclear levels of P53 protein. Also, a slight increase in P53 phosphorylation was observed, which is known to stabilize the P53 protein ( Figure   5A ). To confirm P53 activation after OTX2 induction, we transfected wild-type and mutant reporter constructs for P53 activity into MED8A-OTX2 and MED8A-control cells. The results plotted in Figure 5B show an up to 4-fold increase in luciferase activity after OTX2 induction in MED8A-OTX2 cells, but not in MED8A-control cells or in MED8A-OTX2 cells transfected with a mutated reporter construct. These data suggest that P53 activity may play a role in the OTX2-induced senescence in MED8A, comparable to the known role of P53 in senescence induced by other oncogenes [21, 22] .
OTX2 expression induces senescence-associated secretory factors in DAOY cells
As P53 and P16 (CDKN2A) are mutated in DAOY cells, the OTX2-induced senescence in these cells must involve other pathways. Senescence-associated secretory factors involved in insulin-like growth factor signaling or inflammation have been shown to play a role in oncogene-induced senescence [24] [25] [26] . To investigate whether they are involved in the OTX2-induced senescence in DAOY cells, we examined the expression of several candidate secretory factors by Western blot analysis. Indeed, the expression of senescenceassociated secretory factors IL-6 [27] and IGFBP7 [28] was strongly increased after OTX2 induction ( Figure 5C ). As IL-6 and IGFBP7 signaling have been associated with activated RAS signaling, we also investigated whether RAS signaling was activated after OTX2 induction.
Both the levels of phosphorylated ERK and SPRY2, a known target of RAS signaling, were also elevated after OTX2 induction. The levels of phosphorylated RB decreased after OTX2 induction, in line with the observed diminished cell proliferation. These data show that OTX2 induction causes senescence in both medulloblastoma cell lines, but the mechanisms involved are different.
Mitotic genes are enriched for OTX2 binding
We performed ChIP-on-chip analysis to investigate which genes and processes were likely to be directly regulated by OTX2. Of all expressed genes, 17.6% had one or more significant Table S4 ). Figure   6 shows the OTX2 binding patterns as obtained with the ChIP-on-chip analyses for some representative regulated genes. We analyzed whether the percentage of OTX2 binding was enriched among genes up-or down-regulated after OTX2 induction. OTX2 binding was significantly enriched among regulated genes (20.7%) and even stronger among upregulated genes (22.2%) when compared with nonregulated genes (17.0%) ( Figure 7A ). Moreover, analysis of the nine clusters of regulated genes identified by K-means clustering ( Figure   3 ) showed a strong enrichment of OTX2 binding (31.8%) for genes in cluster IX, which are associated with mitosis and chromosome segregation. Similar results were obtained when we used larger or smaller regions around the TSSs or different cutoffs for OTX2 binding (data not shown). Our data suggest that OTX2 may function as a transcriptional activator and that genes regulating the mitotic cell cycle are among the direct targets of OTX2.
Gene regulation and OTX2 binding compared with the mRNA data of primary tumors
We analyzed whether genes that correlate in expression with OTX2 in tumors were enriched for OTX2 binding. We used the mRNA expression profiles of medulloblastoma tumors [9] , but excluded the profiles of type A and type B tumors. Type B tumors, characterized by activated SHH signaling, have no or very low OTX2 expression. Including these tumors would result in many genes that correlate with OTX2 expression but, in fact, represent subtype-specific differences not related to OTX2. Type A tumors, characterized by activated 49 WNT signaling, were excluded because of the very different genetic background compared with other subtypes.
Of all genes expressed in C, D, and E (CDE) tumors, 17.1% showed binding of OTX2 in MED8A cells ( Figure 7B ). Genes that positively correlate with OTX2 expression in CDE tumors were enriched for OTX2 binding, and this enrichment increased to >25% when we used more stringent cutoffs for correlation with OTX2 expression ( Figure 7B) . In contrast, genes that negatively correlate with OTX2 expression were not enriched for OTX2 binding and even 
Mitotic genes are among the most promising direct targets of OTX2
To identify which of the regulated genes in MED8A are most likely direct targets of OTX2 in medulloblastoma, we combined all data (Supplementary Table S6 ). Thirty-one genes were downregulated and bound by OTX2 and had a negative correlation with OTX2 expression in tumors ( Figure 7F ). Eighty genes were upregulated and bound by OTX2 and had a positive correlation in tumors ( Figure 7G ). As expected, the upregulated genes include several G2-M-associated genes, such as CDC25C, CCNG2, RCBTB1, DSN1, NDE1, SGOL2, CDC40, CEP57, and CEP70 ( Figure 6 ). Strikingly, this list also includes genes that negatively regulate the G1-S transition, such as HBP1, E2F8, and CDKN3 ( Figure 6 ). Moreover, GSPT1, which is necessary for G1-S transition, is one of the downregulated genes. Overall, these candidate OTX2 targets seem to promote G2-M while inhibiting G1-S transition.
To evaluate whether these stringently selected genes were also regulated by OTX2 in and DAOY cells. OTX2-induced senescence was not anticipated, as both cell lines that have no endogenous OTX2 express low levels of OTX1, which encodes a functional homologue of OTX2 [29] . Medulloblastoma tumors without OTX2 expression also have OTX1 expression, although in most cases at low levels [2] . However, the proliferation of MED8A and DAOY cells was apparently not compatible with high OTX2 levels. Nevertheless, we identified genes Oncogene-induced senescence was first described in cells with overexpression of constitutively activated RAS genes [30] . These oncogenes are able to transform cells, but only in collaboration with other oncogenes such as MYC [31, 32] . Similar results have been described for ectopic expression of other components of the RAS pathway, such as RAC1 and RAF [33, 34] , as well as other oncogenes, including E2F and STAT5A [35, 36] . Although, in most studies, these experiments were conducted in primary fibroblasts or other primary cell lines, oncogene-induced senescence has also been described in tumor cell lines [37, 38] . The molecular mechanisms underlying oncogene-induced senescence are complex, but most signals seem to converge on the RB and P53 pathways [22] , as observed in MED8A cells. Accordingly, virtually all human cancers lack functional RB and P53 pathways and thereby escape from senescence [39] . Alternative mechanisms of oncogene-induced senescence involve the activation of senescence-associated secretory factors [22, 23, 25] , as observed in DAOY cells after OTX2 induction for IL-6 [27] and IGFBP7 [28] . Interestingly, these secretory factors were not activated in MED8A cells after OTX2 induction (Supplementary Table S1 ), most likely because they were suppressed by P53 [40] .
Expression profiling of MED8A cells showed that, among many others, mitosis-related genes 53 were initially upregulated, followed by a decrease at later time points (cluster IX of Figure   3 and 4A). Furthermore, these genes were enriched for OTX2 binding to the TSS region and for positive correlation with OTX2 expression in tumors ( Figure 7A and C), suggesting that they represent direct targets of OTX2. These data further hint at an initial stimulation of cell proliferation. Such an effect has been described for other oncogenes that induce senescence [35, 41, 42] . We also observed a slight increase in cell proliferation shortly after OTX2 induction in MED8A and DAOY cells before the onset of senescence and reduced cell proliferation (Supplementary Figure S1) . This initial increase in proliferation in our model is modest, which might be due to the higher basal proliferation rates of cancer cells relative to the fibroblast cells used in other studies. In addition, already early after OTX2 induction, G1-S cell cycle genes were downregulated ( Figure 4B and C) . This imbalance in cell cycle regulation by OTX2 probably creates stress that leads to P53 pathway activation, such as in MED8A cells, or, when P53 is mutated, to activation of senescence-associated secretory factors, such as in DAOY cells. Expression profiling and reporter assays of MED8A cells showed activation of P53 and its downstream target genes after induction of OTX2.
Most medulloblastomas express high OTX2 levels [9] . We hypothesize that inactivation of the P53 pathway is one of the potential mechanisms in medulloblastoma to prevent OTX2-induced senescence. However, P53 mutation or amplification of MDM2, which inhibits P53, has been infrequently reported for medulloblastoma [20, [43] [44] [45] [46] . However, PPM1D, shown to inhibit P53 in medulloblastoma, is highly overexpressed in most medulloblastoma and even amplified in some [9, [47] [48] [49] .
Furthermore, to prevent an imbalance in cell cycle regulation induced by OTX2, medulloblastomas must have found ways to drive G1-S transition. CCND1, CCND2, CDK4, CDK6, and MYC are all highly expressed in medulloblastoma ( Figure 4B and Supplementary   Table S1 ). In some tumors, this is caused by gene amplifications [9, 49, 50] . Especially MYC, but also its family members MYCN and MYCL, are frequently amplified in medulloblastomas [9, 51] . If not amplified, these genes are transcriptionally upregulated as direct targets of the WNT or SHH signaling pathway, which are constitutively activated in ∼40% of medulloblastomas [9, 52] .
The potential role of OTX2 as a positive regulator of cell cycle progression, as suggested by the regulation of mitosis genes, fits with our observation that, in normal cerebellum, OTX2 is mainly expressed in proliferating progenitor cells, but not in differentiated neurons [2] . It is also in line with the results reported by Yan and colleagues that silencing of OTX2 in D425 cells inhibited proliferation and induced differentiation [4, 10] . However, ectopic 54 expression of OTX2 alone is apparently not sufficient to drive proliferation and instead results in senescence in both MED8A and DAOY cells. Here, we present the first data about the genes and pathways regulated by OTX2. OTX2 directly and indirectly upregulates genes associated with the G2-M phase of the cell cycle. These data are confirmed in D425 cells in which we silenced OTX2 expression using inducible shRNA. Microarray and OTX2 ChIPon-chip analyses performed for these cells also identified the mitotic cell cycle genes as one of the major categories of direct targets of OTX2. The full description of these data will be published elsewhere [53] . Our results emphasize the role of OTX2 as an oncogene. In addition, our data obtained with MED8A and DAOY cells also suggest that cooperating genes are required for a balanced acceleration of the cell cycle by OTX2 in medulloblastoma.
Supplementary data
EdU time course
For quantification of cell cycle distribution and S-phase in time, 100 ng/mL doxycycline was added to cells 24 h after plating. After different time points of OTX2 induction, cells were incubated with EdU for 1 hr and subsequently fixed and labeled using the Click-iT™ EdU Cell Proliferation Assay Kit (Invitrogen) as prescribed by the manufacturer. Cells were analyzed on the BD FACSCanto flow cytometer (BD Bioscience). Obtained data were analyzed using FlowJo 7.2 software (Tree Star Inc., Ashland, USA).
Additional annotation expression data
Whether regulated genes in the MED8A-OTX2 cells after OTX2 induction were overexpressed or underexpressed in medulloblastoma tumors versus normal brain tissues was determined by comparing the 2 log expression data of 62 medulloblastoma tumors [9] to the 2 log expression data of 169 arrays of normal brain tissues [11] using the in-house developed software tool R2. A gene was assigned as over-or underexpressed in medulloblastoma when
P<1E
-5 (Supplementary Table S1 ). Furthermore, we calculated the correlation value r between 2 log expression data of OTX2 and the regulated genes in MED8A-OTX2 in tumors. Pearson correlations were calculated in R2. Functional and gene ontology annotation data for genes were acquired using SOURCE (http://smd.stanford.edu/cgi-bin/source/sourceBatchResult).
qPCR validation ChIP
For ChIP on chip validation (Supplementary Table S5 ), samples from an independent experiment were analysed with SYBR Green based quantitative PCR. Primer pairs were checked for specificity by melting curve analysis and gel electrophoresis. Primer pair efficiencies were determined by the slope of PCR curves, which were comparable at different template concentrations, and by performing PCR reactions with different dilutions of a known template. A complete list of primers used for ChIP analysis is listed in the Supplementary Table S11 .
qPCR validation expression
For first-strand cDNA synthesis 1 μg of total RNA from DAOY-OTX2 was reverse transcribed using 125 pM oligodT12 primers, 0.5 mM dNTPs, 2 mM MgCl2, RT-buffer (Invitrogen) and 100 U superscript II (Invitrogen) in a total volume of 25 μl. The cDNA was diluted two times to a total volume of 50 μl. A fluorescence-based kinetic real-time PCR was performed using the real-time iCycler PCR platform (Biorad) in combination with the intercalating fluorescent
